EuromContact contributes to MHRA consultation on the recognition of CE-Marked medical devices
EuromContact has submitted its contribution to the public consultation launched by the Medicines and Healthcare products Regulatory Agency (MHRA) on the indefinite recognition of CE-marked medical devices in Great Britain.
In its response, EuromContact expressed strong support for maintaining alignment between Great Britain and EU transitional timelines for legacy medical devices, highlighting the importance of regulatory consistency to ensure continuity of supply and patient access. The association also supported the indefinite recognition of devices compliant with the EU Medical Device Regulation (MDR), noting that this would reduce unnecessary duplication, facilitate market access, and maintain high standards of patient safety.